• No se han encontrado resultados

TítuloCirculating angiotensin converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

N/A
N/A
Protected

Academic year: 2020

Share "TítuloCirculating angiotensin converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease"

Copied!
16
0
0

Texto completo

Loading

Figure

FIGURE  1.  Circulating  ACE2  (A)  and  ACE  (B)  enzymatic  activities  at  increased  concentrations  of  zinc  chloride  (ZnCl 2 )
Table 1. Clinical characteristics of study cohorts
Table 2. ICCs and percentage of recovery for ACE2 and ACE activities between different sample conditions
FIGURE 2. Circulating ACE2 activity between studied groups. (A) ACE2 activity significantly  decreased in CKD3-5 (grey bars)  and CKD5D (white bars) patients as compared with CONT (black bars) (*P < 0.001)
+4

Referencias

Documento similar

George Respiratory Questionnaire and Chronic Obstructive Pulmonary Disease Assessment Test in patients with chronic obstructive pulmonary disease based on correlation and

Liabeuf et al., “Serum indoxyl sul- fate is associated with vascular disease and mortality in chronic kidney disease patients,” Clinical Journal of the American Society of

ATR2, angiotensin receptor 2; BNP, brain natriuretic peptide; CCL5, chemokine (C-C Motif) ligand 5; COVID-19, coronavirus disease-19; CRP, C-reactive protein; CV, cardiovascular;

Objective: We examined physician perception of blood pressure control and treatment behavior in patients with previous cardiovascular disease and uncontrolled hypertension as defined

Abbreviations: ACE, angiotensin converting enzyme; Ang II, angiotensin II, ARB, angiotensin receptor blockers; ARE, antioxidant responsive element; AT1R, angiotensin II receptor type

The patients with ADPKD included in the study had worse renal function (worse mean estimated by glomerular filtration rate [eGFR], more in patients with CKD stage 4) and

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE), Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney

A Study on the Relationship between Serum Beta 2-Microglobulin Levels, Underlying Chronic Kidney Disease, and Peripheral Arterial Disease in High-Vascular-Risk